Pfizer Marks 2021 With Spin On DNA’s Double Helix As Its New Logo
Image via Pfizer
Pfizer has unveiled its new logo online, describing it as a signal of the company’s transition from commerce to science.”
The pharmaceutical company has replaced its blue oval pill background with a blue-toned double helix spiral resembling a DNA molecule. Its tagline, “Breakthroughs that changes patients’ lives,” however, remains the same.
“We’ve unlocked the pill form to reveal the core of what we do,” Pfizer explained on its website. The company also released two new videos—the first explaining its logo and the second one focusing on its Science Will Win campaign.
“Our identity reflects the dignity of Pfizer’s history and captures the innovative spirit and science focus alive in the company today,” shared Sally Susman, Pfizer’s executive VP and chief corporate affairs officer.
The new logo took 18 months of work and would help boost Pfizer’s reputation following its announcement of the BNT162B2 coronavirus vaccine, which it developed together with Germany-based company BionNTech.
In order to realize the breakthroughs of the future, we’ve revolutionized how we work today. We're unlocking the pill to reveal Pfizer’s DNA: the power of science. pic.twitter.com/NO0TWt6OVh
— Pfizer Inc. (@pfizer) January 5, 2021
Encoded within a successful emblem is a company’s DNA – its history, its future. @Pfizer’s new corporate brand identity is a digital-first expression of our commitment to the transformative power of science. It’s a dynamic reflection of our purpose. pic.twitter.com/vNqCgWus4w
— AlbertBourla (@AlbertBourla) January 5, 2021
After more than 170 years of preventing and curing disease, @Pfizer has arrived at a new era – a time of extraordinary focus on our science and the value it brings to patients. pic.twitter.com/raQBJA5qph
— AlbertBourla (@AlbertBourla) January 5, 2021
New brand identity for Pfizer!! here is how the logo has evolved. https://t.co/GDQd3fdOFp pic.twitter.com/upnyTQprpt
— Anand Prabu (@anandprabu) January 6, 2021
[via Fierce Pharma, cover image via Pfizer]
